In summary, this work has demonstrated the feasibility of a LAMP assay comprising HPV 16 and 18 DNA/RNA and tumor markers hTERT, TERC and MYC for early detection of cervical cancer using prospectively collected cytology samples from patients with newly diagnosed cervical cancer and in normal controls. The gene discussed is TERC; the disease is cervical carcinoma.